Clinical Outcome After Implantation of Two Different Multifocal Toric IOLs: Liberty (677MTY) and PanOptix®

NCT05895396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2024-08-30

No results posted yet for this study

Summary

This study is to compare the rotational stability, visual outcome and patient satisfaction after implantation with either Liberty 677MTY, a multifocal diffractive-refractive IOL based on EPS technology manufactured by Medicontur Ltd. (Zsámbék, Hungary) or the multifocal toric IOL PanOptix®, manufactured by Alcon.

Conditions

  • Cataract

Sponsors & Collaborators

  • Medicontur Medical Engineering Ltd

    lead INDUSTRY

Principal Investigators

  • József F Győry, MD · Retinaszerviz Kft. (8200 Veszprém, Vörösmarty tér 6, Hungary)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2024-05-10
Completion
2024-05-10

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05895396 on ClinicalTrials.gov